BCMA+ EV Levels Correlate With Myeloma Response to Belantamab-Mafodotin
December 6, 2023
“Measurement of BCMA-EV can thus help in identifying resistance mechanisms and side effects of BCMA targeted therapies in future studies.” BUFFALO, NY- December 6, 2023 – A new research paper… read more